The therapy of Alzheimer's disease primarily relies on drugs, and the approved drugs on the market include acetylcholinesterase drugs, glutamate receptor antagonists, and amyloid-β monoclonal antibodies. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.